Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
Journal of Infection, vol.88, no.3, 2024 (SCI-Expanded, Scopus)
- Publication Type: Article / Letter
- Volume: 88 Issue: 3
- Publication Date: 2024
- Doi Number: 10.1016/j.jinf.2024.106120
- Journal Name: Journal of Infection
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, Aquatic Science & Fisheries Abstracts (ASFA), CAB Abstracts, CINAHL, Veterinary Science Database
- Hacettepe University Affiliated: Yes